EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liquid biopsies for the monitoring of gliomas and brain metastases in adults

Govert Dwarshuis, Lente L Kroon, Dieta Brandsma, David P Noske, Myron G Best, Nik Sol

Acta Neuropathologica · 2025

DOI: 10.1007/s00401-025-02880-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, 2025. Verfasst von Govert Dwarshuis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Brain Tumor Center Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Biomarkers, Tumor. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical evaluation and MR imaging are currently the cornerstone of brain tumor progression monitoring. However, this is complicated by the occurrence of treatment effects such as pseudoprogression and radionecrosis. While essential for patient management, the distinction from true progression remains a significant challenge. Moreover, MR imaging provides limited real-time insights into tumor heterogeneity, genetic divergence, and treatment resistance. Although surgical histopathological biopsies can yield additional valuable information, they are not always conclusive, invasive, and therefore, not suitable for longitudinal measurements. In the era of precision medicine, there is a critical need for minimally invasive, accurate, and cost-effective monitoring methods for both primary brain tumors and brain metastases. Liquid biopsies have emerged as a potential candidate. Various analytes, including circulating nucleic acids, extracellular vesicles, platelet RNAs, and circulating tumor cells, can be obtained from whole blood and its derivatives, as well as other body fluids such as cerebrospinal fluid. In this narrative review, we outline the potential of liquid biopsies for the management of gliomas and brain metastases in adults and emphasize their utility in monitoring disease progression and treatment response. We discuss the most studied biofluids and analytes, along with their respective advantages and downsides. Furthermore, we address key considerations for future research and biobanking to pave the way for clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaBiomarkers, TumorHumansLiquid BiopsyAdultNeoplastic Cells, CirculatingDisease Progression

Stichwörter der Autor:innen

BiomarkersBrain metastasesBrain tumorsGliomaLiquid biopsyMonitoring

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Brain Tumor Center Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Neurology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Neurology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands. n.sol@nki.nl.

Förderung

  • KWF Kankerbestrijding

Zitieren

APA

Dwarshuis, G., Kroon, L. L., Brandsma, D., Noske, D. P., Best, M. G., & Sol, N. (2025). Liquid biopsies for the monitoring of gliomas and brain metastases in adults. Acta Neuropathologica. https://doi.org/10.1007/s00401-025-02880-9

Vancouver

Dwarshuis G, Kroon LL, Brandsma D, Noske DP, Best MG, Sol N. Liquid biopsies for the monitoring of gliomas and brain metastases in adults. Acta Neuropathologica. 2025. doi:10.1007/s00401-025-02880-9

BibTeX
@article{Dwarshuis2025,
  author = {Dwarshuis, Govert and Kroon, Lente L and Brandsma, Dieta and Noske, David P and Best, Myron G and Sol, Nik},
  title = {Liquid biopsies for the monitoring of gliomas and brain metastases in adults},
  journal = {Acta Neuropathologica},
  year = {2025},
  doi = {10.1007/s00401-025-02880-9}
}
Kostenlos starten →